Cancer risks in blood pressure medicines

Cancer risks in blood pressure medicines

University Hospitals Case Medical Center cardiologists discover cancer risks in blood pressure meds – University Hospitals Case Medical Center cardiologists have uncovered new research showing an increased risk of cancer with a group of blood pressure medications known as angiotensin-receptor blockers (ARBs).

Shark cartilage drug AE-941 does not improve lung cancer survival

AE-941, a standardized shark cartilage, does not improve lung cancer survival – The anti-cancer drug AE-941, a shark cartilage derivative, did not improve overall survival in patients with inoperable stage III non-small cell lung cancer, according to a study published online May_26 in the Journal of the National Cancer Institute.

Gene biomarker to identify smokers for lung cancer risk

Researchers discover new approach for identifying smokers at highest risk for developing lung cancer – Researchers from Boston University School of Medicine (BUSM) in collaboration with investigators at the University of Utah, have discovered a new approach for identifying smokers at the highest risk for developing lung cancer.

Racial differences in lung cancer beliefs

Survey finds significant racial differences in lung cancer beliefs – A new survey finds that while both whites and African Americans know and think little about lung cancer, African Americans are more likely to hold beliefs and perceptions about the disease that could interfere with prevention and treatment.

Quitting smoking doubles survival in lung cancer patients

Lung cancer patients who quit smoking double their survival chances – People diagnosed with early stage lung cancer can double their chances of survival over five years if they stop smoking compared with those who continue to smoke.

Green tea may reduce lung cancer risk in smokers

Green tea could modify the effect of cigarette smoking on lung cancer risk – Drinking green tea could modulate the effect of smoking on lung cancer. Results of this hospital-based, randomized study conducted in Taiwan were presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held here from Jan_11-14, 2010.

Biomarkers for ovarian cancer rise a year before diagnosis

Assessing lead time of selected ovarian cancer biomarkers – Concentrations of the biomarkers CA125, human epididymis protein 4 (HE4), and mesothelin began to rise 3 years before clinical diagnosis of ovarian cancer, according to a new study published online December 30 in the Journal of the National Cancer Institute.

Pistachios may reduce lung cancer risk

Pistachios may reduce lung cancer risk – A diet that incorporates a daily dose of pistachios may help reduce the risk of lung and other cancers, according to data presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference.

Secondhand smoke exposure increases lung cancer risk

Secondhand smoke exposure in childhood increases lung cancer risk later in life – Children exposed to secondhand cigarette smoke have an increased risk of developing lung cancer in adulthood, even if they never smoked.

Cancer mortality declined in Europe

New figures on cancer in Europe show a steady decline in mortality but big variations — Large variations in mortality exist between countries and between men and women – New figures on deaths from cancer in Europe show a steady decline in mortality between the periods 1990-1994 and 2000-2004. Deaths from all cancers in the European Union (EU) between these two periods fell by nine percent in men and eight percent in women, with a large drop among the middle-aged population.